9 completed, 1 terminated, 1 withdrawn. 11 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 9, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Nicoderm: new trials by email Literature Review of Nicoderm trials Research Report on Nicoderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Nicotine patch, Placebo patch, E-cigarettes - Nicotine Dependence, Cigarettes | Phase 2 | Completed | Duke University | 94 | 2018-08-06 | 2023-02-08 |
| Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment Nicotine patch, ENDS, Placebo patch - Nicotine Dependence | Phase 2 | Withdrawn | Duke University | 2018-07-01 | 2018-09-12 | |
| Combination Nicotine Patch / Lorcaserin for Smoking Cessation lorcaserin, nicotine patch, placebo lorcaserin - Nicotine Dependence | Phase 2 | Completed | Duke University | 97 | 2016-11-08 | 2019-05-07 |
| Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence | Phase 2 / Phase 3 | Terminated | Centre for Addiction and Mental Health | 18 | 2015-07-01 | 2018-07-19 |
| Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers Nicotine Patch, Moclobemide - Nicotine Dependence | Phase 2 | Completed | Jed E. Rose | 76 | 2013-09-01 | 2017-08-23 |
| Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate Ganaxolone, Nicotine Patch - Smoking Cessation | Phase 2 | Completed | Jed E. Rose | 36 | 2013-06-01 | 2014-09-08 |
| Meclizine as a Potential Smoking Cessation Treatment Meclizine, Nicotine Patch, Placebo - Smoking Cessation | Phase 2 | Completed | Duke University | 146 | 2011-08-01 | 2014-08-01 |
| Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function Nicotine Replacement Therapy (NRT), Gamma-Tocopherol, Placebo - Endothelial Dysfunction | Phase 1 / Phase 2 | Completed | University of Connecticut | 67 | 2011-01-01 | 2015-01-21 |
| Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use Usual Care Group, Reduction Group - Tobacco Use Disorder | Phase 2 | Completed | University of Minnesota | 332 | 2006-11-01 | 2017-10-16 |
| Comparing Smoking Treatment Programs for Lighter Smokers - 1 nicotine transdermal system, bupropion, Medication Management - Tobacco Use Disorder | Phase 2 | Completed | University of Pennsylvania | 260 | 2003-09-01 | 2019-08-06 |
| Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1 Nicotine Replacement Therapies, Nicotine patch, Folic Acid - Smoking Cessation, Tobacco Use Disorder | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 128 | 2002-04-01 | 2017-01-10 |
Smoking Cessation (8) · Tobacco Use Disorder (8) · Cigarette Smoking (4) · Vaping (2)
Duke University (4) · Jed E. Rose (2) · Centre for Addiction and Mental Health (1) · National Institute on Drug Abuse (NIDA) (1) · University of Connecticut (1) · University of Minnesota (1) · University of Pennsylvania (1)
United States (10) · Canada (1)
Jed E Rose, Ph.D. (4) · Jed E. Rose, Ph.D. (2) · Dorothy Hatsukami, Ph.D. (1) · Dorothy Hatsukami, PhD (1) · James M Davis, M.D. (1) · Laurie Zawertailo, PhD (1) · Peter Selby, MBBS (1) · Peter W Gariti, Ph.D. (1) · Richard S Bruno, PhD, RD (1)
PMID 19339135, PMID 22218402, PMID 24075893, PMID 25361769, PMID 31589323, PMID 34611902, PMID 37230961
P50DA027840 (5), R01DA014404 (1), R01DA015365 (1)